SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Uniting the six native Japanese dog breeds. Kendu is the keeper of peace, the preserver of life, and the protector of unity. Join the pack!!

Kendu

$KENDU.X is gaining attention as community members highlight its strong, active community and real-world applications. Discussions revolve around the increasing holder count, dedicated community initiatives, and the potential for significant growth. The community emphasizes its organic growth and real-world brand building.

Dogecoin is a cryptocurrency based on the popular "Doge" Internet meme and features a Shiba Inu on its logo. Dogecoin is a Litecoin fork. Introduced as a "joke currency" on 6 December 2013, Dogecoin quickly developed its own online community and reached a capitalization of US$60 million in January 2014. Compared with other cryptocurrencies, Dogecoin had a fast initial coin production schedule: 100 billion coins were in circulation by mid-2015, with an additional 5.256 billion coins every year thereafter. As of 30 June 2015, the 100 billionth Dogecoin had been mined.   Dogecoin was created by Billy Markus from Portland, Oregon and  Jackson Palmer from Sydney, Australia. Both wanted to create a fun cryptocurrency that will appeal beyond the core Bitcoin audience. Dogecoin is primarily used as a tipping system on Reddit and Twitter where users tip each other for creating or sharing good content. The community is very active in organising fundraising activities for deserving causes.  The developers of Dogecoin haven’t made any major changes to the coin since 2015. This means that Dogecoin could get left behind and is why Shibas are leaving Dogecoin to join more advanced platforms like Ethereum. One of Dogecoin strengths is its relaxed and fun-loving community. However, this is also a weakness because other currencies are way more professional.  To purchase Dogecoin, it involves downloading a crypto wallet, setting up a crypto exchange account and then trading away for your desired crypto currency. Once we have set up an account with a DOGE currency exchange and deposited some funds, you are ready to start trading.

Dogecoin

Dogecoin is trending as the community discusses potential catalysts, including speculation around a Dogecoin ETF and its impact on price. Sentiment is focused on the potential for significant gains, with some looking toward the token reaching the $1 mark. The conversation also includes discussion around Dogecoin's relationship with other meme coins and their respective ecosystems.

Dog (Bitcoin) is a fully decentralized memecoin on the Bitcoin blockchain, backed by a community dedicated to onboarding millions of people to Bitcoin.  Dog is secured by the Bitcoin blockchain and exists on Bitcoin L1, marking a significant innovation compared to Bitcoin with just BTC. Dog is a Bitcoin Runes token with a minimal on-chain footprint, native to Bitcoin, and stored in UTXOs, just like Bitcoin.   What is the project about?  Dog does not do any paid promotion and is fully decentralized just like Bitcoin. Every influencer who chooses to post about Dog either received the airdrop or bought on secondary. Dog leverages the CC0 license to ensure that Dog is not owned by any single entity but rather by everyone. This had lead to the "DOG Army" independently creating art, apps, lotteries, plushies, websites, podcast, magazines, X account, IRL meetups, clothing lines, PFP collections, Telegram groups, and TikTok/Instagram about Dog.  What makes your project unique?  Dog was airdropped in the fairest memecoin launch ever. In early 2024, the Bitcoin Ordinals ecosystem came together in a full volunteer initiative that rewarded early adopters of the Ordinals Protocol. There was no team allocation, and 100% of the supply was airdropped for free. The airdrop algorithm favored neither whales nor influencers; it was determined by the community and made open-source for maximum transparency.

Dog (Bitcoin)

$DOG.X is trending as the community rallies around its position as the first meme coin on Bitcoin, emphasizing its fair launch and strong community-driven growth. Discussion highlights its unique utility in strengthening the Bitcoin network through miner fees, setting it apart from other meme coins. Some believe $DOG.X has the potential to outperform other meme coins like $DOGE.X.

Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Miami, FL.

Summit Therapeutics Inc

Summit Therapeutics is trending due to positive updated Phase 3 HARMONi data for its lung cancer drug, ivonescimab, sparking optimism about its potential. The community is focused on the drug's OS benefit and its competitive efficacy compared to existing treatments, while also debating the validity and interpretation of trial data. Some investors are speculating about a potential acquisition or partnership, particularly with AstraZeneca, driving further interest in the stock.

ProShares Trust - ProShares Short Dow30 -1x Shares

ProShares Short Dow30

$DOG is trending as the Bitcoin memecoin gains traction within the crypto community, with many touting its fair launch and strong community backing. Conversation highlights its potential to become the meme face of Bitcoin and draw comparisons to other popular memecoins. Community members are emphasizing its organic growth and decentralized nature.

Bankr is an advanced AI agent focused on simplifying the process of buying and selling digital assets. Bankr was the first AI agent on Farcaster to help you quickly buy all your favorites coins directly in the social. BankrCoin is the official coin of the agent and was deployed by Bankr itself directly in the Farcaster social feed. Fees from swaps go to support BankrCoin. Bankr is available on Farcaster and will soon be launching a private terminal, token recs, and limit orders on Base.

BankrCoin

BankrCoin is trending as traders discuss its recent listing on Coinbase and potential for high gains, with some community members pointing to its AI-powered trading platform and the possibility of new partnerships. Bullish sentiment is fueled by the hope of 'dropping zeros' and achieving significant market cap growth. Others are comparing it to similar tokens that have experienced substantial pumps.

DOVU

DOVU.X is trending as the community discusses its staking rewards and potential for real-world asset (RWA) tokenization, particularly following the announcement of their Trust Operating System. Some users are highlighting DOVU's ties to the Hedera network and its potential in the carbon credit space, while others are speculating about upcoming exchange listings.

Seres Therapeutics, Inc. engages in the development of biological drugs through microbiome therapeutics platform. Its product pipeline includes SER-109, SER-287, SER-301, and SER-401. The company was founded by Geoffrey von Maltzahn, David A. Berry, and Noubar B. Afeyan on October 18, 2010 and is headquartered in Cambridge, MA.

Seres Therapeutics Inc

Seres Therapeutics is trending amid community speculation of a potential buyout offer from Nestlé, fueled by reports of a substantial per-share offer that could trigger a major short squeeze given the stock's high short interest. The community is weighing the credibility of the reports, while also considering the implications of recent leadership changes and an upcoming conference presentation. Some investors believe a deal is imminent, while others are waiting for official confirmation and evaluating the potential for milestone payments.

Gyrodyne LLC engages in the management of a portfolio of medical office and industrial properties. Its properties include Flowerfield, Port Jefferson Professional Park, Courtland Medical Center, and Grove. The company was founded by Peter James Papadakos in 1946 and is headquartered in St. James, NY.

Gyrodyne LLC

GYRO is trending due to a recent land sale agreement, potentially boosting its NAV, which has captured the attention of traders. The stock's low float is fueling discussions of a potential squeeze, with community members actively watching for breakout levels. Some are betting on a significant upward move, drawing comparisons to other low-float runners.

Cameco Corp. engages in the provision of uranium. It operates through the Uranium and Fuel Services segments. The Uranium segment is involved in the exploration for, mining, milling, purchase, and sale of uranium concentrate. The Fuel Services segment deals with the refining, conversion, and fabrication of uranium concentrate and the purchase and sale of conversion services. The company was founded in 1988 and is headquartered in Saskatoon, Canada.

Cameco Corp.

Cameco ($CCJ) is trending amid renewed interest in nuclear energy, potentially driven by Trump administration executive orders and the increasing power demands of AI data centers. Community discussions highlight analyst upgrades, strong technical setups, and potential benefits from Westinghouse holdings, while also noting overbought conditions and potential pullbacks. Some investors are favoring US-based uranium companies like $UEC due to potential domestic policy tailwinds.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Oncology in Focus: How Emerging Therapies Are Reshaping Cancer Treatment

Oncology in Focus: How Emerging Therapies Are Reshaping Cancer Treatment Oncology in Focus: How Emerging Therapies Are Reshaping Cancer Treatment PR Newswire VANCOUVER, BC, Dec. 26, 2024 USA News...

Erasca Inc. Poised for Growth: Buy Rating Maintained Amidst Promising Trial Updates and Solid Financials

Chris Shibutani, an analyst from Goldman Sachs, maintained the Buy rating on Erasca (ERAS Research Report). The associated price target was lower...

Erasca (NASDAQ:ERAS) PT Raised to $7.00

Erasca (NASDAQ:ERAS - Free Report) had its target price hoisted by The Goldman Sachs Group from $6.00 to $7.00 in a research report sent to investors on Tuesday morning, Benzinga reports. The...

Erasca's Promising Naporafenib Data and Financial Stability Merit a Buy Rating

Analyst Graig Suvannavejh from Mizuho Securities maintained a Buy rating on Erasca (ERAS Research Report) and keeping the price target at $7.00...

HC Wainwright Reiterates "Buy" Rating for Erasca (NASDAQ:ERAS)

HC Wainwright restated their buy rating on shares of Erasca (NASDAQ:ERAS - Free Report) in a report issued on Thursday, Benzinga reports. HC Wainwright currently has a $8.00 price objective on the...

Erasca, Inc. (ERAS) R&D Update Call and Q4 2023 Earnings Call Transcript

Erasca, Inc. (ERAS) R&D Update Call and Q4 2023 Earnings Call Transcript...

Erasca Inc (ERAS) Aligns with EPS Projections, Reveals Robust Balance Sheet and Key Clinical ...

Insights into Erasca Inc's Q4 and Full Year 2023 Financial and Operational PerformanceRelated Stocks: ERAS...

Erasca's Strong Clinical Data and Enhanced Financial Position Support Buy Rating

In a report released today, Naureen Quibria from Capital One Financial reiterated a Buy rating on Erasca (ERAS Research Report), with a price tar...

Erasca Announces $45 Million Oversubscribed Private Placement Financing

Funding from new and existing investors extends anticipated cash runway into H2 2026SAN DIEGO, March 27, 2024 (GLOBE NEWSWIRE) -- Erasca, Inc. (Nasdaq: ERAS) ( Erasca ), a clinical-stage precision...

Erasca, Inc. is a clinical stage precision oncology company. It focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. It has assembled a wholly owned or controlled RAS/MAPK pathway focused pipeline comprising modality-agnostic programs. The company was founded by Jonathan E. Lim and Kevan Shokat on July 2, 2018 and is headquartered in San Diego, CA.

Fiscal Period	Estimated	Reported	Surprise	Result
Q3 '25	-$0.10	--	--	N/A
Q2 '25	-$0.12	-$0.12	-3.86%	MISSED
Q1 '25	-$0.12	-$0.11	11.59%	BEAT
Q4 '24	-$0.12	-$0.11	11.78%	BEAT
Q3 '24	-$0.17	-$0.11	34.16%	BEAT

ERAS
Erasca Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest Earnings Results: Q2 '25

Historical Earnings

Latest ERAS News

ERAS Erasca Inc